| Bioactivity | Ecabet sodium (TA-2711) is currently applied to some gastrointestinal disease by inhibiting the ROS production and improving Helicobacter pylori eradication[1]. Ecabet sodium reduces apoptosis[2]. |
| Target | ROS production; Bacterial; Apoptosis |
| Name | Ecabet sodium |
| CAS | 86408-72-2 |
| Formula | C20H27NaO5S |
| Molar Mass | 402.48 |
| Appearance | Solid |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
| Reference | [1]. Wang Y, et al. Efficacy and safety of ecabet sodium as an adjuvant therapy for Helicobacter pylori eradication: a systematic review and meta-analysis. Helicobacter. 2014 Oct;19(5):372-81. [2]. Rah YC, et al. Ecabet sodium alleviates neomycin-induced hair cell damage. Free Radic Biol Med. 2015 Dec;89:1176-83. [3]. Kenji Kusumoto, et al. Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells. Am J Physiol Gastrointest Liver Physiol |
Ecabet sodium
CAS: 86408-72-2 F: C20H27NaO5S W: 402.48
Ecabet sodium(TA-2711) is currently applied to some gastrointestinal disease by inhibiting the ROS production and improv
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.